Patient Retention in HIV Medical Care in a Primary Care Practice in Australia
RiC
2 other identifiers
observational
1,537
1 country
1
Brief Summary
The purpose of this study is to determine linkage and retention in care in patients with HIV infection and reasons for loss to follow up Care in a High HIV-caseload Inner City Primary Care Practice in Sydney, Australia. The investigators hypothesise that patients attending HHMP will have higher rates of linkage and retention in care than the US HIV-infected population, and equivalent to Australian modelling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedFirst Submitted
Initial submission to the registry
June 5, 2014
CompletedFirst Posted
Study publicly available on registry
June 18, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedSeptember 21, 2015
September 1, 2015
1.3 years
June 5, 2014
September 17, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome measures are the rates of current linkage and retention in care for HIV-infected adults at Holdsworth House Medical Practice (HHMP) over a 5-year period
Up to 5 years
Secondary Outcomes (1)
A secondary outcome measure is to determine the factors associated with loss to follow up (LTFU) in the study population over a 5-year period
Up to 5 years
Other Outcomes (6)
Determining the reasons for LTFU - death, move to another practice, move interstate or overseas, other reason, unknown
Up to 5 years
The proportion of patients on antiretroviral therapy vs. not on therapy
Up to 5 years
The proportion of patients with undetectable viral load i.e. most recent plasma HIV RNA <50 copies/mL
Up to 5 years
- +3 more other outcomes
Study Arms (2)
Retained in Care
Each patient who had at least 2 practice visits separated by ≥90 days in a year involving HIV laboratory monitoring until 31st of March 2014.
Lost to follow-up (LTFU)
Each patient who had at 2 practice visits separated by ≥90 days in a year involving HIV laboratory monitoring but did not maintain regular attendance at HHMP until 31st March, 2014.
Eligibility Criteria
HIV-infected patients attending HHMP from 1st January 2009 to 31st March 2014 inclusive, who had at least 2 practice visits separated by ≥90 days in a year involving HIV laboratory monitoring whilst attending HHMP.
You may qualify if:
- Documented HIV-1 infection
- Attendance during the study period for at least 2 visits \>3 months and \<12 months apart with measured laboratory virological or immunological markers (either on-site or at a co-management site)
You may not qualify if:
- Attendance by patient with HIV infection who does not have laboratory markers of HIV viral load or CD4 count measured
- Initial visit after 1st January 2014
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Holdsworth House Medical Practicelead
- Gilead Sciencescollaborator
Study Sites (1)
Holdsworth House Medical Practice
Darlinghurst, New South Wales, 2010, Australia
Related Publications (7)
Hall HI, Halverson J, Wilson DP, Suligoi B, Diez M, Le Vu S, Tang T, McDonald A, Camoni L, Semaille C, Archibald C. Late diagnosis and entry to care after diagnosis of human immunodeficiency virus infection: a country comparison. PLoS One. 2013 Nov 5;8(11):e77763. doi: 10.1371/journal.pone.0077763. eCollection 2013.
PMID: 24223724BACKGROUNDGardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011 Mar 15;52(6):793-800. doi: 10.1093/cid/ciq243.
PMID: 21367734BACKGROUNDCenters for Disease Control and Prevention (CDC). Vital signs: HIV prevention through care and treatment--United States. MMWR Morb Mortal Wkly Rep. 2011 Dec 2;60(47):1618-23.
PMID: 22129997BACKGROUNDMugavero MJ, Lin HY, Willig JH, Westfall AO, Ulett KB, Routman JS, Abroms S, Raper JL, Saag MS, Allison JJ. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis. 2009 Jan 15;48(2):248-56. doi: 10.1086/595705.
PMID: 19072715BACKGROUNDDas M, Chu PL, Santos GM, Scheer S, Vittinghoff E, McFarland W, Colfax GN. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One. 2010 Jun 10;5(6):e11068. doi: 10.1371/journal.pone.0011068.
PMID: 20548786BACKGROUNDFang CT, Hsu HM, Twu SJ, Chen MY, Chang YY, Hwang JS, Wang JD, Chuang CY; Division of AIDS and STD, Center for Disease Control, Department of Health, Executive Yuan. Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. J Infect Dis. 2004 Sep 1;190(5):879-85. doi: 10.1086/422601. Epub 2004 Jul 22.
PMID: 15295691BACKGROUNDGiordano TP, Visnegarwala F, White AC Jr, Troisi CL, Frankowski RF, Hartman CM, Grimes RM. Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure. AIDS Care. 2005 Aug;17(6):773-83. doi: 10.1080/09540120412331336652.
PMID: 16036264BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Mark T Bloch, MBBS
Holdsworth House Medical Practice
Study Design
- Study Type
- observational
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
June 5, 2014
First Posted
June 18, 2014
Study Start
June 1, 2014
Primary Completion
September 1, 2015
Study Completion
September 1, 2015
Last Updated
September 21, 2015
Record last verified: 2015-09